by Katie Hogan | Jul 29, 2026 | Market Access
| Author: Alison Kneen, Global Market Access Practice Lead, BioVid The timeline between clinical development and commercial launch is shrinking. Not because science is moving faster, but because regulators, HTA bodies, and market access expectations are becoming...
